Today
July 25, 2026Dilution Risk
5Last 7DListing Risk
37Last 30DEarnings
9Last 7DInsider / Ownership
3Last 14DDividends
1Last 30DFDA / Clinical
7Last 30DINVO Fertility's 10-Q is delayed due to auditor transition and complex accounting reviews, impacting financial statement finalization.
iSpecimen Inc. reported a severe 85.25% drop in Q1 2026 revenue and a 37.20% increase in net loss, prompting a going concern warning due to recurring losses and negative working capital.
Apimeds Pharmaceuticals US, Inc.
WORK Medical Technology Group LTD's FY2025 revenue decreased 14.4% to $9.85 million, but the company significantly narrowed its net loss to $1.20 million and achieved positive operating cash flow of $6.24 million.
ZenaTech's 2025 revenue surged 558% to $12.9M, primarily from its new DaaS segment, but net loss expanded to $(45.2)M due to increased finance, wage, and G&A expenses, with negative operating cash flow.
Nebius Group N.V.
TeraWulf's Q1 2025 results show an 18.9% revenue decrease to $34.4 million and a widened net loss of $61.4 million, primarily due to increased power costs and bitcoin network difficulty, partially offset by strong operating cash flow.
Satellogic's Q1 2026 revenue surged 80.3% to $6.1 million, but net loss dramatically widened to $(118.3) million, primarily due to a non-cash fair value adjustment of financial instruments.
AST SpaceMobile reported a 28.4% increase in Q2 2025 revenue to $1.16 million, but net loss widened to $(99.39) million, primarily due to higher operating expenses and a significant loss on warrant liabilities.
Traws Pharma reported a net income of $9.2 million for FY2025, a significant turnaround from a $166.5 million net loss in FY2024, primarily due to a non-cash change in warrant liability....
Traws Pharma's 10-K filing is delayed due to ongoing financing efforts and substantial doubt about its ability to continue as a going concern.
Nocera, Inc. reported a 19.9% decrease in annual revenue to $13.6 million for FY2025, while narrowing its net loss by 35.8% to $(2.9) million....
Moleculin Biotech reported a widened net loss of $(33.56)M for FY2025, a 28.8% increase from the prior year. However, cash and cash equivalents surged 107.5% to $8.88M, extending the funding runway into Q3 2026....
Circle Internet Group's FY2025 revenue surged 63.9% to $2.75 billion, but the company posted a net loss of $69.5 million, a significant decline from the prior year's $155.7 million net income, largely due to...
Shopify reported a 30.1% increase in revenue to $11.56 billion and a 36.6% rise in operating income to $1.47 billion for FY2025....
Spotify Technology S.A. delivered strong financial results for fiscal year 2025, with revenue up 10.77% to €17.19 billion and net income surging 94.38% to €2.21 billion, driven by Premium subscriber growth.
NIO Inc. reported a 33.1% increase in revenues to RMB87.49 billion and a 33.3% reduction in net loss to RMB14.94 billion for FY2025, alongside a shift to positive operating cash flow.
ASML Holding NV reported a strong fiscal year 2025, with total net sales increasing by 15.6% to €32.7 billion and net income rising 26.9% to €9.61 billion.
HSBC's annual operating profit and net income declined in FY 2025, with a substantial decrease in operating cash flow. The company aims for 5% YoY revenue growth by 2028 and a 17% RoTE, but will pause share buy-backs...
Novo Nordisk reported a 6.4% increase in revenue to DKK 309.06 billion for FY 2025, but operating profit slightly decreased by 0.5%. Net profit grew modestly by 1.4% to DKK 102.43 billion....